
Oncocross
Discovering drugs that can satisfy unmet needs in numerous diseases and medical conditions.
Enterprise value
$96m
Share price
KRW9160.00
Company register number
4828600109
Get premium to view all results
Date | Investors | Amount | Round |
---|---|---|---|
- | investor | €0.0 | round |
N/A | €0.0 | round | |
investor investor investor investor investor investor investor investor investor investor | €0.0 | round | |
investor investor investor | €0.0 | round | |
investor investor investor investor investor | €0.0 Valuation: €0.0 | round | |
* | N/A | KRW85.6b | IPO |
Total Funding | 000k |

Magna Investment(exited)

SmileGate Investment(exited)

ID Ventures(exited)

SM Sino Technology Investment(exited)

Wooshin Venture Investment(exited)

HBIC(exited)

Vision creator(exited)

KDB Capital(exited)

KB Securities(exited)

Hana Financial Group(exited)

Nau IB Capital(exited)

InterVest(exited)

Pathfinder H(exited)

ST Capital(exited)

Dongwha Pharm(exited)

Moru Asset Management(exited)

Quantum Ventures Korea(exited)
KRW | 2024 |
---|---|
Revenues | 0000 |
EBITDA | 0000 |
% EBITDA margin | (612 %) |
Profit | 0000 |
% profit margin | (605 %) |
EV | 0000 |
EV / revenue | 00.0x |
EV / EBITDA | 00.0x |
R&D budget | 0000 |
Source: Company filings or news article
Related Content
Notes (0)
Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads
Tech stack
Tech stackLearn more about the technologies and tools that this company uses.